Sarepta shares plunge 40% as future of its gene therapy appears at risk
Douglas Ingram, president and chief executive officer of Sarepta Therapeutics Inc., during the Forbes Healthcare Summit in New York, US, ...
Tag: Sarepta Therapeutics Inc
Douglas Ingram, president and chief executive officer of Sarepta Therapeutics Inc., during the Forbes Healthcare Summit in New York, US, ...
